ApoC-III deficiency prevents hyperlipidemia induced by apoE overexpression

This publication has 30 references indexed in Scilit:

• Relative contribution of variation within the APOC3/A4/A5 gene cluster in determining plasma triglycerides
  Human Molecular Genetics, 2002
• Contribution of Apolipoprotein C-III Gene Variants to Determination of Triglyceride Levels and Interaction With Smoking in Middle-Aged Men
  Arteriosclerosis, Thrombosis, and Vascular Biology, 2000
• Variation of Candidate Genes in Triglyceride Metabolism
  European Journal of Cardiovascular Risk, 2000
• Characterization of Recombinant Wild Type and Site-Directed Mutations of Apolipoprotein C-III: Lipid Binding, Displacement of ApoE, and Inhibition of Lipoprotein Lipase
  Biochemistry, 2000
• Overexpression and Accumulation of Apolipoprotein E as a Cause of Hypertriglyceridemia
  Published by Elsevier ,1998
• Nascent very-low-density lipoprotein triacylglycerol hydrolysis by lipoprotein lipase is inhibited by apolipoprotein E in a dose-dependent manner
  Biochemical Journal, 1997
• Apolipoprotein E Effectively Inhibits Lipoprotein Lipase-mediated Lipolysis of Chylomicron-like Triglyceride-rich Lipid Emulsions and
  Published by Elsevier ,1996
• Inhibition of lipoprotein lipase by the receptor‐binding domain of apolipoprotein E
  FEBS Letters, 1989
• Apolipoprotein B metabolism in subjects with deficiency of apolipoproteins CIII and AI. Evidence that apolipoprotein CIII inhibits catabolism of triglyceride-rich lipoproteins by lipoprotein lipase in vivo.
  Journal of Clinical Investigation, 1986
• Is decreased activity of C-II activated lipoprotein lipase in type III hyperlipoproteinemia (broad-β-disease) a cause or an effect of increased apolipoprotein E levels?
  Metabolism, 1976